Cargando…

The kynurenine pathway in schizophrenia, bipolar disorder, and major depressive disorder: a systematic review and meta-analysis of cerebrospinal fluid studies

INTRODUCTION: The kynurenine pathway has been suggested to be involved in the pathophysiology of psychiatric disorders, including schizophrenia (SZ), bipolar disorder (BD), and major depressive disorder (MDD). OBJECTIVES: To conduct a systematic review and meta-analysis of the kynurenine pathway met...

Descripción completa

Detalles Bibliográficos
Autores principales:	Salagre, E., Fernandes, B. S., Inam, M. E., Grande, I., Vieta, E., Quevedo, J., Zhao, Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cambridge University Press 2023
Materias:	Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10660770/ http://dx.doi.org/10.1192/j.eurpsy.2023.1291

Ejemplares similares

The kynurenine pathway in major depressive disorder, bipolar disorder, and schizophrenia: a systematic review and meta-analysis of cerebrospinal fluid studies
por: Inam, Mehmet Enes, et al.
Publicado: (2023)

Clinical predictors of kynurenine pathway aberrations in schizophrenia and bipolar disorder
por: Skorobogatov, K., et al.
Publicado: (2022)

Onset and relapse prevention of bipolar disorders
por: Vieta, E.
Publicado: (2023)

Mitochondrial Variants in Schizophrenia, Bipolar Disorder, and Major Depressive Disorder
por: Rollins, Brandi, et al.
Publicado: (2009)

PS195. Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder
por: Ogawa, Shintaro, et al.
Publicado: (2016)

Increased Matrix Metalloproteinases in Cerebrospinal Fluids of Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2020)

Risk Calculators in Bipolar Disorder: A Systematic Review
por: Silva Ribeiro, Joana, et al.
Publicado: (2020)

The Role of Base Excision Repair in Major Depressive Disorder and Bipolar Disorder
por: Kucuker, M., et al.
Publicado: (2022)

PS238. Altered balance between monoamine metabolites in human cerebrospinal fluid with major depressive disorder.
por: Yoon, Hyung Shin, et al.
Publicado: (2016)

Increased cerebrospinal fluid fibrinogen in major depressive disorder
por: Hattori, Kotaro, et al.
Publicado: (2015)

Electroconvulsive therapy following incident bipolar disorder: When, how, and for whom?
por: Salagre, Estela, et al.
Publicado: (2022)

Genetic Liabilities Differentiating Bipolar Disorder, Schizophrenia, and Major Depressive Disorder, and Phenotypic Heterogeneity in Bipolar Disorder
por: Richards, Alexander L., et al.
Publicado: (2022)

Structural neuroimaging differentiates between depressed bipolar disorder and major depressive disorder patients: a machine learning study
por: Calesella, F., et al.
Publicado: (2023)

Precision in bipolar disorders
por: Grande, I.
Publicado: (2023)

Mindfulness, Attention, and Impulsivity in Bipolar Disorder
por: Fares-Otero, N. E., et al.
Publicado: (2023)

Kynurenine pathway abnormalities are state-specific but not diagnosis-specific in schizophrenia and bipolar disorder
por: Skorobogatov, Katrien, et al.
Publicado: (2023)

The tryptophan catabolite or kynurenine pathway in major depressive and bipolar disorder: A systematic review and meta-analysis
por: Almulla, Abbas F., et al.
Publicado: (2022)

Toward Precision Psychiatry in Bipolar Disorder: Staging 2.0
por: Salagre, Estela, et al.
Publicado: (2018)

PS46. Distinct and shared morphometric biomarkers of depressed individuals with bipolar disorder and major depressive disorder
por: Matsuo, Koji, et al.
Publicado: (2016)

Reduced cerebrospinal fluid ethanolamine concentration in major depressive disorder
por: Ogawa, Shintaro, et al.
Publicado: (2015)

Reduced Cerebrospinal Fluid Levels of Lysophosphatidic Acid Docosahexaenoic Acid in Patients With Major Depressive Disorder and Schizophrenia
por: Omori, Wataru, et al.
Publicado: (2021)

The response to unfolded proteins in schizophrenia and bipolar disorder
por: Cachán, C., et al.
Publicado: (2023)

Common and Specific Functional Activity Features in Schizophrenia, Major Depressive Disorder, and Bipolar Disorder
por: Yang, Yongfeng, et al.
Publicado: (2019)

Reduced Serum and Cerebrospinal Fluid Levels of Autotaxin in Major Depressive Disorder
por: Itagaki, Kei, et al.
Publicado: (2019)

Cerebrospinal fluid proteome evaluation in major depressive disorder by mass spectrometry
por: Franzen, Avery D., et al.
Publicado: (2020)

PM539. Evaluation of plasma and cerebrospinal fluid G72 protein levels and their correlations with psychiatric symptoms in schizophrenia and major depression
por: Ishiwata-Matsushima, Sayuri, et al.
Publicado: (2016)

C-reactive protein in a naturalistic sample of inpatients with major depressive disorder, bipolar disorder and obsessive-compulsive disorder
por: Caldirola, D., et al.
Publicado: (2021)

Integrating proteomic and clinical data to discriminate major psychiatric disorders: Applications for major depressive disorder, bipolar disorder, and schizophrenia
por: Shin, Dongyoon, et al.
Publicado: (2022)

Microscopic Particles in Two Fractions of Fresh Cerebrospinal Fluid in Twins with Schizophrenia or Bipolar Disorder and in Healthy Controls
por: Johansson, Viktoria, et al.
Publicado: (2012)

PS192. A study of tryptophan, kynurenine and serotonin transporter in first-episode, drug-naïve patients with major depressive disorder
por: Chiu, Yen-Chen, et al.
Publicado: (2016)

Bipolar disorders and suicide: stumbling twice with the same stone?
por: Sagué-Vilavella, M., et al.
Publicado: (2022)

Involvement of Kynurenine Metabolism in Bipolar Disorder: An Updated Review
por: Zhang, Peifen, et al.
Publicado: (2021)

4.4 INTERNET-BASED INTERVENTIONS FOR BIPOLAR DISORDER
por: Hidalgo-Mazzei, Diego, et al.
Publicado: (2018)

Classification for psychiatric disorders including schizophrenia, bipolar disorder, and major depressive disorder using machine learning
por: Yang, Qingxia, et al.
Publicado: (2022)

Peripheral tryptophan and serotonin and kynurenine pathways in major depression: A case-control study
por: Colle, R., et al.
Publicado: (2021)

Cerebrospinal fluid proteomic study of two bipolar disorder cohorts
por: Isgren, Anniella, et al.
Publicado: (2022)

Bipolar disorder correlated to shorter remission latency and borderline personality disorder symptom severity to longer in depression – a prospective cohort study of major depressive patients
por: Söderholm, J., et al.
Publicado: (2022)

Cognitive Impairment in Bipolar Disorder: Treatment and Prevention Strategies
por: Solé, Brisa, et al.
Publicado: (2017)

Overlapping of clinical symptoms between schizophrenia and bipolar disorder
por: Tahirovic, A., et al.
Publicado: (2022)

Is emotion dysregulation correlated to depressive and manic symptoms of bipolar disorder? Results from a systematic review and network meta-analysis
por: Oliva, V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_pccc3f1horn48snuilt612ieef